AKT1 and glaucoma: Importantly, inhibition of PI3K/Akt inhibited Id1 and ITGA4 expression, resulting in the decreasing biological function of EPCs.35 Based on the pathway enrichment results, we can draw the conclusion that PI3K‐Akt was the potential downstream pathways in glaucoma.